Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2076 studies found for:    "Acute non lymphoblastic leukemia"
Show Display Options
Rank Status Study
21 Completed Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: Topotecan;   Drug: Fludarabine;   Drug: Cytarabine
22 Active, not recruiting Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: Bexarotene
23 Recruiting HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: idarubicin;   Biological: microtransplantation
24 Completed
Has Results
Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients
Condition: Acute Myeloid Leukemia
Interventions: Drug: AZD1152;   Drug: LDAC
25 Recruiting Protocol in Acute Myeloid Leukemia With FLT3-ITD
Condition: Acute Myeloid Leukemia
Interventions: Drug: Midostaurin;   Drug: Cytarabine;   Drug: Daunorubicin
26 Completed LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)
Condition: Acute Myeloblastic Leukemia
Intervention: Drug: gemtuzumab
27 Completed Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML)
Condition: Acute Myeloblastic Leukaemia
Intervention: Drug: panobinostat
28 Completed
Has Results
Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia (AML);   Adult Acute Myeloblastic Leukemia
Interventions: Drug: Lenalidomide;   Drug: Azacitidine
29 Completed Velcaflagida in Relapsed or Refractary Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: Bortezomib
30 Terminated Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: AKN-028
31 Completed Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)
Condition: Acute Myeloid Leukaemia
Intervention: Drug: AZD1152
32 Completed Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: Decitabine 15 mg/m2 i.v.
33 Terminated Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: Plerixafor granulocyte-colony stimulating factor
34 Terminated A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.
Condition: Acute Myeloid Leukemia
Interventions: Procedure: Two post-remission strategies;   Drug: Idarubicin versus daunorubicin
35 Active, not recruiting A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: OCV-501;   Drug: Placebo
36 Completed Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older
Condition: Acute Myeloid Leukemia
Intervention: Drug: ZARNESTRA, tipifarnib, R115777
37 Completed A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention: Drug: panobinostat/LBH589B
38 Completed Differentiation Induction in Acute Myelogenous Leukemia
Condition: Acute Myelogenous Leukemia
Interventions: Drug: all-trans retinoic acid (ATRA);   Drug: Valproic acid;   Drug: Theophyllin
39 Not yet recruiting Study of Crenolanib in Combination Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations
Condition: Acute Myeloid Leukemia
Interventions: Drug: chemotherapy (Mitoxantrone, Cytarabine);   Drug: Placebo;   Drug: Crenolanib;   Other: Allogeneic stem cell transplantation
40 Unknown  Development of a Diagnostic Kit for FLT3-ITD in Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.